Cargando…
Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy
Inhalable nanostructured microparticles of simvastatin, a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor, were rationally designed for targeted pulmonary delivery as dry powder inhalers (DPIs) for the treatment of pulmonary hypertension (PH). Advanced particle engineering design technology was...
Autores principales: | Acosta, Maria F., Muralidharan, Priya, Grijalva, Carissa L., Abrahamson, Michael D., Hayes, Don, Fineman, Jeffrey R., Black, Stephen M., Mansour, Heidi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968029/ https://www.ncbi.nlm.nih.gov/pubmed/33719747 http://dx.doi.org/10.1177/1753466621998245 |
Ejemplares similares
-
Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (Rock) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery
por: Muralidharan, Priya, et al.
Publicado: (2021) -
Comparison of L-Carnitine and L-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH
por: Acosta, Maria F., et al.
Publicado: (2020) -
Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy
por: Muralidharan, Priya, et al.
Publicado: (2021) -
RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension
por: Barman, Scott A, et al.
Publicado: (2009) -
Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
por: Acosta, Maria F., et al.
Publicado: (2020)